In support of the above statement, endocannabinoid system stimulation has shown promise as a strategy for individuals with headaches, as it activates both CB1 and CB2 cannabinoid receptors, as well as certain TRP channels, leading to reduced neuroinflammation, pain, and improved quality of life [58,139]. This evidence concerns the gene CNR2 and Headache.